Using our novel platform technology, we at Nanotein, help overcome the CAR-T industry challenges by: (1) accelerating CAR-T expansion, (2) enhancing expansion to grow more cells per treatment, and (3) shifting the growth profile of CAR-T cultures to favor the expansion of the most long-lived and clinically effective CAR-T cell sub-populations.
The uniquely tunable and flexible nature of our platform technology also allows us to easily modify our product. With the ability to make these simple changes we can grow CAR-T and T-cell cultures with new cell population profiles and growth curves.
Company Details
- Employees
- 5
- Founded
- 2019
- Address
- 2865 Seventh St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.nanoteintech.com/
- Keywords
- cell therapy.
- HQ
- Berkeley, CA
Nanotein Technologies, Inc. Questions
Nanotein Technologies, Inc.'s website is https://www.nanoteintech.com/
Nanotein Technologies, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nanotein-technologies
Nanotein Technologies, Inc. has
5 employees.
View email and phone details for 5
employees at Nanotein Technologies, Inc..
Nanotein Technologies, Inc.'s industry is
Biotechnology Research
Nanotein Technologies, Inc.'s top competitors are
Akron Bio,
Amberstone Biosciences,
Caribou Biosciences,
Adanate,
Ansa Biotechnologies, Inc.,
Xaira Therapeutics,
Biomap,
Actym Therapeutics, Inc.,
Machaon Diagnostics,
Immunebridge.
Nanotein Technologies, Inc.'s categories are Biotechnology Research
Nanotein Technologies, Inc.'s founding year is 2019
